RA Capital Nexus Fund III, L.P.
Director; Director, 10% Owner · 27 filings · Latest: Aug 12, 2026
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Freenome, Inc.
Mineralys Therapeutics, Inc.
Parabilis Medicines, Inc.
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SEPN | RA Capital Nexus Fund III, L.P. | Director | Aug 12, 2026 | Sale | $42.50 | 1,493,000 | $63.5M | 725,443 | |
SEPN | RA Capital Nexus Fund III, L.P. | — | Aug 12, 2026 | Proposed Sale | $48.19 | 746,500 | $36.0M | — | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 31, 2026 | Purchase | $9.93 | 24,944 | $247.7K | 17,329,570 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 29, 2026 | Purchase | $9.99 | 20,824 | $208.0K | 17,304,626 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 24, 2026 | Purchase | $9.99 | 41,319 | $412.8K | 17,283,802 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 23, 2026 | Purchase | $9.96 | 59,880 | $596.4K | 17,242,483 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 22, 2026 | Purchase | $9.93 | 84,124 | $835.4K | 17,182,603 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 21, 2026 | Purchase | $9.55 | 120,582 | $1.2M | 17,098,479 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 13, 2026 | Purchase | $8.94 | 6,522 | $58.3K | 16,817,543 | |
PBLS | RA Capital Nexus Fund III, L.P. | Director | Jul 22, 2026 | Purchase | $29.77 | 47,250 | $1.4M | 26,529,686 | |
PBLS | RA Capital Nexus Fund III, L.P. | Director | Jul 21, 2026 | Purchase | $29.25 | 65,923 | $1.9M | 26,482,436 | |
PBLS | RA Capital Nexus Fund III, L.P. | Director | Jul 20, 2026 | Purchase | $27.28 | 131,420 | $3.6M | 26,416,513 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 17, 2026 | Purchase | $8.95 | 7,882 | $70.5K | 16,977,927 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 16, 2026 | Purchase | $8.93 | 152,472 | $1.4M | 16,970,045 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 13, 2026 | Purchase | $8.94 | 6,552 | $58.6K | 16,817,573 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jul 10, 2026 | Purchase | $8.97 | 15,102 | $135.5K | 16,811,021 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jun 26, 2026 | Purchase | $8.98 | 1,876 | $16.8K | 16,795,919 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jun 25, 2026 | Purchase | $8.88 | 31,000 | $275.3K | 16,794,043 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jun 16, 2026 | Purchase | $8.89 | 124,893 | $1.1M | 16,763,043 | |
ARTV | RA Capital Nexus Fund III, L.P. | Director | Jun 15, 2026 | Purchase | $8.99 | 15,414 | $138.6K | 16,638,150 |
Page 1 of 2
Next →